Dual-specificity phosphatase regulation in neurons and glial cells
R Pérez-Sen, MJ Queipo, JC Gil-Redondo… - International Journal of …, 2019 - mdpi.com
Dual-specificity protein phosphatases comprise a protein phosphatase subfamily with
selectivity towards mitogen-activated protein (MAP) kinases, also named MKPs, or mitogen …
selectivity towards mitogen-activated protein (MAP) kinases, also named MKPs, or mitogen …
Multiple sclerosis is linked to MAPKERK overactivity in microglia
GJA Ten Bosch, J Bolk, BA 't Hart, JD Laman - Journal of Molecular …, 2021 - Springer
Reassessment of published observations in patients with multiple sclerosis (MS) suggests a
microglial malfunction due to inappropriate (over) activity of the mitogen-activated protein …
microglial malfunction due to inappropriate (over) activity of the mitogen-activated protein …
Deep Parallel Characterization of AAV Tropism and AAV-Mediated Transcriptional Changes via Single-Cell RNA Sequencing
Engineered variants of recombinant adeno-associated viruses (rAAVs) are being developed
rapidly to meet the need for gene-therapy delivery vehicles with particular cell-type and …
rapidly to meet the need for gene-therapy delivery vehicles with particular cell-type and …
High-content single-cell combinatorial indexing
RM Mulqueen, D Pokholok, BL O'Connell… - Nature …, 2021 - nature.com
Single-cell combinatorial indexing (sci) with transposase-based library construction
increases the throughput of single-cell genomics assays but produces sparse coverage in …
increases the throughput of single-cell genomics assays but produces sparse coverage in …
The integrated stress response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer
N Ghaddar, S Wang, B Woodvine… - Nature …, 2021 - nature.com
The integrated stress response (ISR) is an essential stress-support pathway increasingly
recognized as a determinant of tumorigenesis. Here we demonstrate that ISR is pivotal in …
recognized as a determinant of tumorigenesis. Here we demonstrate that ISR is pivotal in …
Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking
X Ruan, P Du, K Zhao, J Huang, H Xia, D Dai… - Chinese Medicine, 2020 - Springer
Background At present, coronavirus disease 2019 (COVID-19), caused by infection with
severe acute respiratory syndrome coronavirus 2, is spreading all over the world, with …
severe acute respiratory syndrome coronavirus 2, is spreading all over the world, with …
Molecular and functional landscape of malignant serous effusions for precision oncology
Personalized treatment for patients with advanced solid tumors critically depends on the
deep characterization of tumor cells from patient biopsies. Here, we comprehensively …
deep characterization of tumor cells from patient biopsies. Here, we comprehensively …
m6A methyltransferase Wilms' tumor 1‐associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual‐specificity …
HY Ma, LY Shen, H Yang, HT Gong, XJ Du, JB Li - IUBMB life, 2021 - Wiley Online Library
Nasal‐type natural killer/T‐cell lymphoma (NKTCL) is an aggressive malignancy with poor
survival outcomes that is relatively resistant to chemotherapy. N6‐Methyladenosine (m6A) …
survival outcomes that is relatively resistant to chemotherapy. N6‐Methyladenosine (m6A) …
MAPK-negative feedback regulation confers dependence to JAK2V617F signaling
M Kesarwani, Z Kincaid, M Azhar, J Menke… - Leukemia, 2023 - nature.com
Despite significant advances in developing selective JAK2 inhibitors, JAK2 kinase inhibitor
(TKI) therapy is ineffective in suppressing the disease. Reactivation of compensatory MEK …
(TKI) therapy is ineffective in suppressing the disease. Reactivation of compensatory MEK …
Dissecting mechanisms of melanoma resistance to BRAF and MEK inhibitors revealed genetic and non-genetic patient-and drug-specific alterations and remarkable …
ML Hartman, M Sztiller-Sikorska, A Gajos-Michniewicz… - Cells, 2020 - mdpi.com
The clinical benefit of MAPK pathway inhibition in BRAF-mutant melanoma patients is
limited by the development of acquired resistance. Using drug-naïve cell lines derived from …
limited by the development of acquired resistance. Using drug-naïve cell lines derived from …